Raghu Sinha All publications ( 24 ) Sinha R. Pinto JT. Facompre N. Kilheffer J. Baatz JE. El-Bayoumy K. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells. 2008 Mar-Apr. Nutr Cancer. 60(2):267-75. El-Bayoumy K. Sinha R. Pinto JT. Rivlin RS. Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. 2006 Mar. J Nutr. 136(3 Suppl):864S-869S. National Cancer Institute El-Bayoumy K. Das A. Narayanan B. Narayanan N. Fiala ES. Desai D. Rao CV. Amin S. Sinha R. Molecular targets of the chemopreventive agent 1,4-phenylenebis (methylene)-selenocyanate in human non-small cell lung cancer. 2006 Jul. Carcinogenesis. 27(7):1369-76. National Cancer Institute El-Bayoumy K. Sinha R. Molecular chemoprevention by selenium: a genomic approach. 2005 Dec 11. Mutat Res. 591(1-2):224-36. National Cancer Institute El-Bayoumy K. Sinha R. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. 2004 Jul 13. Mutat Res. 551(1-2):181-97. National Cancer Institute Sinha R. El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. 2004 Feb. Curr Cancer Drug Targets. 4(1):13-28. National Cancer Institute Unni E. Kittrell FS. Singh U. Sinha R. Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine. 2004. Breast Cancer Res. 6(5):R586-92. El-Bayoumy K. Das A. Boyiri T. Desai D. Sinha R. Pittman B. Amin S. Comparative action of 1,4-phenylenebis(methylene)selenocyanate and its metabolites against 7,12-dimethylbenz[a]anthracene-DNA adduct formation in the rat and cell proliferation in rat mammary tumor cells. 2003 Oct 25. Chem Biol Interact. 146(2):179-90. National Cancer Institute Sinha R. Unni E. Ganther HE. Medina D. Methylseleninic acid, a potent growth inhibitor of synchronized mouse mammary epithelial tumor cells in vitro. 2001 Feb 1. Biochem Pharmacol. 61(3):311-7. Said TK. Moraes RC. Sinha R. Medina D. Mechanisms of suberoylanilide hydroxamic acid inhibition of mammary cell growth. 2001. Breast Cancer Res. 3(2):122-33. National Cancer Institute Unni E. Singh U. Ganther HE. Sinha R. Se-methylselenocysteine activates caspase-3 in mouse mammary epithelial tumor cells in vitro. 2001. Biofactors. 14(1-4):169-77. National Cancer Institute Sinha R. Kiley SC. Lu JX. Thompson HJ. Moraes R. Jaken S. Medina D. Effects of methylselenocysteine on PKC activity, cdk2 phosphorylation and gadd gene expression in synchronized mouse mammary epithelial tumor cells. 1999 Nov 15. Cancer Lett. 146(2):135-45. National Cancer Institute Kumar B. Sinha R. Sehgal S. High incidence of IgG antibodies to phenolic glycolipid in non-leprosy patients in India. 1998 Apr. J Dermatol. 25(4):238-41. Sinha R. Medina D. Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells. 1997 Aug. Carcinogenesis. 18(8):1541-7. National Cancer Institute Sinha R. Said TK. Medina D. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. 1996 Oct 22. Cancer Lett. 107(2):277-84. National Cancer Institute Jamba L. Nehru B. Medina D. Bansal MP. Sinha R. Isolation and identification of selenium-labeled proteins in the mouse kidney. 1996 Jul-Aug. Anticancer Res. 16(4A):1651-7. National Cancer Institute Sinha R. Sehgal S. Comparative evaluation of serological tests in Indian kala-azar. 1994 Dec. J Trop Med Hyg. 97(6):333-40. Sinha R. Bansal MP. Ganther H. Medina D. Significance of selenium-labeled proteins for selenium's chemopreventive functions. 1993 Sep. Carcinogenesis. 14(9):1895-900. National Cancer Institute Sinha R. Datta U. Sehgal S. Importance of bone marrow culture for diagnosis of Kala azar. 1993. Scand J Infect Dis. 25(6):787-9. Sehgal S. Sinha R. Mallick A. Arora SK. Hazra PK. Humoral antibody response in Leishmania tropica infection. 1992 May. J Infect. 24(3):311-6. Sinha R. Arora SK. Datta U. Sehgal S. Detection of leishmania antigen in kala azar patients using monoclonal antibodies. 1992. Microbiol Immunol. 36(4):391-400. Arora SK. Sinha R. Sehgal S. Use of in vitro method to assess different brands of anti-leishmanial drugs. 1991. Med Microbiol Immunol (Berl). 180(1):21-7. Sinha R. Arora SK. Sehgal S. Use of whole parasite for quick screening of hybridomas against Leishmania donovani. 1989 Apr. Hybridoma. 8(2):259-61. Sinha R. Arora SK. Sehgal S. A sensitive ELISA for detection of circulating antigens in kala azar patients. 1988 Aug. Indian J Med Res. 88:138-40.